By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pernix Therapeutics, Inc. 

P.O. Box 40

Gonzales  Louisiana  70707-0040  U.S.A.
Phone: 800-793-2145 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Pernix Therapeutics, Inc. (PTX) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/24/2014 10:20:15 AM
Pernix Therapeutics, Inc. (PTX) Submits sNDA For TREXIMET® Use In Adolescent Patients 11/17/2014 11:27:39 AM
Pernix Therapeutics, Inc. (PTX) Reports Third Quarter 2014 Financial Results And Reaffirms Guidance 11/10/2014 10:34:42 AM
Pernix Therapeutics, Inc. (PTX) To Report Q3 2014 Financial Results 10/27/2014 9:13:21 AM
Pozen, Inc. (POZN) Announces U.S. Rights For TREXIMET┬« Have Been Acquired By Pernix Therapeutics, Inc. (PTX) 8/20/2014 8:32:41 AM
Pernix Therapeutics, Inc. (PTX) Reports Second Quarter 2014 Financial Results 8/11/2014 8:51:15 AM
Closing For Pernix Therapeutics, Inc. (PTX) Transaction To Acquire Treximet® Tablets For Migraine From GlaxoSmithKline (GSK) Delayed 8/4/2014 10:56:41 AM
Pernix Therapeutics, Inc. (PTX) To Report Second Quarter 2014 Financial Results On August 11, 2014 7/25/2014 9:23:53 AM
Pernix Therapeutics, Inc. (PTX) Appoints Chief Financial Officer 6/23/2014 11:09:21 AM
GlaxoSmithKline (GSK), Pernix Therapeutics, Inc. (PTX) Ink $250 Million Migraine Drug Deal 5/14/2014 6:21:13 AM
123456789
//-->